ClinVar Miner

Submissions for variant NM_000138.5(FBN1):c.4441A>G (p.Ser1481Gly)

gnomAD frequency: 0.00113  dbSNP: rs61730054
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 15
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000029736 SCV000052389 uncertain Marfan syndrome 2011-08-18 criteria provided, single submitter curation Converted during submission to Uncertain significance.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000035201 SCV000058843 likely benign not specified 2018-12-31 criteria provided, single submitter clinical testing The p.Ser1481Gly variant in FBN1 is classified as likely benign because it has b een identified in 0.4% (97/24962) of African chromosomes by gnomAD (http://gnoma d.broadinstitute.org). ACMG/AMP Criteria applied: BS1.
Eurofins Ntd Llc (ga) RCV000724063 SCV000229808 uncertain significance not provided 2014-09-03 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000515317 SCV000611391 uncertain significance Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome 2017-05-23 criteria provided, single submitter clinical testing
Ambry Genetics RCV001176800 SCV000738752 likely benign Familial thoracic aortic aneurysm and aortic dissection 2017-11-07 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Invitae RCV001088381 SCV000753160 likely benign Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection 2024-01-24 criteria provided, single submitter clinical testing
Center for Human Genetics, Inc, Center for Human Genetics, Inc RCV000029736 SCV000781370 likely benign Marfan syndrome 2016-11-01 criteria provided, single submitter clinical testing
SIB Swiss Institute of Bioinformatics RCV000029736 SCV000803588 likely benign Marfan syndrome 2018-05-31 criteria provided, single submitter curation This variant is interpreted as a Likely Benign, for Marfan syndrome, in Autosomal Dominant manner. The following ACMG Tag(s) were applied: BP2 => Observed in trans with a pathogenic variant for a fully penetrant dominant gene/disorder or observed in cis with a pathogenic variant in any inheritance pattern (PMID:21542060). BS2 => Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000035201 SCV000883854 likely benign not specified 2018-10-02 criteria provided, single submitter clinical testing
GeneDx RCV000724063 SCV000977387 likely benign not provided 2020-12-07 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 24793577, 21542060, 27647783)
Color Diagnostics, LLC DBA Color Health RCV001176800 SCV001340855 likely benign Familial thoracic aortic aneurysm and aortic dissection 2018-11-14 criteria provided, single submitter clinical testing
Johns Hopkins Genomics, Johns Hopkins University RCV000029736 SCV001469041 likely benign Marfan syndrome 2020-12-07 criteria provided, single submitter clinical testing
Centre of Medical Genetics, University of Antwerp RCV000029736 SCV002025458 uncertain significance Marfan syndrome 2021-03-01 criteria provided, single submitter research PP4
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV001176800 SCV002041985 benign Familial thoracic aortic aneurysm and aortic dissection 2019-10-29 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004541020 SCV004761636 likely benign FBN1-related disorder 2021-04-14 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.